Fustibal
Recent News About Fustibal
-
Biotech company questions validity of Bayer's drug patent
SAN FRANCISCO – A biotech company has filed a petition that questions the validity of Bayer’s patent on its cancer drug Stivarga.
Friday, April 4, 2025